345
Participants
Start Date
January 31, 2015
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
ALX-0061
Placebo
Methotrexate
Stable background dose of commercially available methotrexate (not provided by the Sponsor).
Investigator Site 1, Skopje
Investigator Site 2, Skopje
Investigator Site, Budapest
Investigator Site, Brussels
Investigator Site, Brussels
Investigator Site, Sofia
Investigator Site, Sofia
Investigator Site, Chisinau
Investigator Site, Szikszó
Investigator Site, Liège
Investigator Site, Plovdiv
Investigator Site, Békéscsaba
Investigator Site, Gyula
Investigator Site, Pleven
Investigator Site, Baja
Investigator Site 1, Rousse
Investigator Site 2, Rousse
Investigator Site, Székesfehérvar
Investigator Site, Veszprém
Investigator Site, Balatonfüred
Investigator Site, Ghent
Investigator Site, Varna
Investigator Site, New York
Investigator Site, Berlin
Investigator Site 1, Belgrade
Investigator Site 2, Belgrade
Investigator Site 3, Belgrade
Investigator Site, Brooklyn
Investigator Site, Prague
Investigator Site, Santiago de Compostela
Investigator Site, Niška Banja
Investigator Site, Lublin
Investigator Site, Novi Sad
Investigator Site, Hamburg
Investigator Site, Monclova
Investigator Site, Madrid
Investigator Site, Madrid
Investigator Sie, Charleston
Investigator Site, Myrtle Beach
Investigator Site, Stockbridge
Investigator Site, Orlando
Investigator Sites, Hialeah
Investigator Site, Miami Lakes
Investigator Site, Homestead
Investigator Site, Miami
Investigator Site, Birmingham
Investigator Site, León
Investigator Site, Salamanca
Investigator Site, Memphis
Investigator Site, Katowice
Investigator Site, Cologne
Investigator Site, Brno
Investigator Site, Poznan
Investigator Site, Bad Nauheim
Investigator Site, Monterrey
Investigator Site, Monterrey
Investigator Site, Overland Park
Investigator Site, Monroe
Investigator Site, Mesquite
Investigator Site, Zlín
Investigator Site, Olomouc
Investigator Site, Culiacán
Investigator Site, Gdynia
Investigator Site, Elblag
Investigator Site, Bydgoszcz
Investigator Site, Torun
Investigator Site, Albuquerque
Investigator Site, Los Angeles
Investigator site, Los Angeles
Investigator Site, La Palma
Investigator Site, Hemet
Investigator Site, Ventura
Investigator Site, Sochaczew
Investigator Site, Mérida
Investigator Site, Timișoara
Investigator Site, Oradea
Investigator Site, Târgu Mureş
Investigator Site, Brăila
Investigator Site, Worcester
Investigator Site, Prague
Investigator Site, Berlin
Investigator Site, Frankfurt
Investigator Site, Elblag
Investigator Site, Tbilisi
Investigator Site 1, Tbilisi
Investigator Site 2, Tbilisi
Investigator Site, Tbilisi
Investigator Site, Tbilisi
Investigator Site 1, Mexico City
Investigator Site 2, Mexico City
Investigator Site, Grodzisk Mazowiecki
Investigator Site, Warsaw
Investigator Site, Bucharest
Investigator Site, Bucharest
Ablynx, a Sanofi company
INDUSTRY